首页> 外文期刊>BMC Nephrology >Relation of multi-marker panel to incident chronic kidney disease and rapid kidney function decline in African Americans: the Jackson Heart Study
【24h】

Relation of multi-marker panel to incident chronic kidney disease and rapid kidney function decline in African Americans: the Jackson Heart Study

机译:多标志板对事件慢性肾病的关系和非裔美国人的快速肾功能下降:杰克逊心脏研究

获取原文
           

摘要

Few investigations have evaluated the incremental usefulness of multiple biomarkers representing varying physiological pathways for predicting risk of renal outcomes in African Americans. We related a multi-marker panel to incident chronic kidney disease (CKD) and rapid kidney function decline (RKFD) in 2813 Jackson Heart Study participants without prevalent CKD at exam 1 (2000-2004) and with complete assays at exam 1 for 9 biomarkers: adiponectin, aldosterone, B-natriuretic peptide [BNP], cortisol, high sensitivity C-reactive protein (hsCRP), endothelin, homocysteine, plasma renin activity and mass. Incident CKD was defined as estimated glomerular filtration rate (eGFR)??60?mL/min/1.73?m2 at exam 3 while RKFD was defined as eGFR ≥30% loss between exams 1 and 3 (8.2 median years). We employed multiple logistic regression model to describe association between the panel and incident CKD and RKFD and used backward elimination strategy to estimate the most parsimonious biomarker model while controlling for conventional risk factors. The multi-marker panel predicted the risk for both incident CKD (odds ratios [OR], 2.72; 95% confidence intervals [CI], 1.63, 4.56; P?=?0.001) and RKFD (2.61; 95% CI, 1.67, 4.08; P??0.001). Per standard deviation increase in log biomarker concentrations were significantly (multivariable adjusted odds ratios, [95% confidence interval], p-value) associated with incident CKD: plasma adiponectin (1.24 [1.07, 1.44], p?=?0.005) and leptin (1.3 [1.06, 1.61], p?=?0.011), and with RKFD: plasma adiponectin (1.22 [1.06, 1.40], p?=?0.006); hsCRP (1.17 [1.01, 1.36], p?=?0.031) and aldosterone (0.85 [0.74, 0.96], p?=?0.012). Moderate levels (3rd quartile) of aldosterone were inversely associated with incident CKD (0.54 [0.35, 0.82], p?=?0.004) while leptin was associated with RKFD (1.64 [1.10, 2.44], p?=?0.015). Biomarkers improved CKD risk prediction (P?=?0.003) but not RKFD risk prediction (P?=?0.10). In this community-based sample of African Americans, a multi-marker panel added only moderate predictive improvement compared to conventional risk factors.
机译:很少有调查已经评估了代表不同生理途径的多种生物标志物的增量有用性,以预测非洲裔美国人肾脏成果的风险。我们与事件慢性肾病(CKD)和肾脏功能迅速(RKFD)相关的多标记面板在2813年杰克逊心脏研究参与者在考试1(2000-2004)中没有普遍存在的CKD,并在考试中的完全测定为9个生物标志物:脂联素,醛固酮,B-natrietic肽[BNP],皮质醇,高敏感性C-反应蛋白(HSCRP),内皮素,同型半胱氨酸,血浆肾素活性和质量。入射CKD定义为估计的肾小球过滤速率(EGFR)?在考试中的β-6?mL / min / 1.73?M2,而RKFd定义为EGFR≥30%的考试1和3(8.2个中位数)之间的损失。我们采用多个Logistic回归模型来描述小组和事件CKD和RKFD之间的关联,并使用落后消除策略来估计最令人置捉地区的生物标志物模型,同时控制常规风险因素。多标记面板预测入射CKD的风险(大量比率[或],2.72; 95%置信区间[CI],1.63,4.56; P?= 0.001)和RKFD(2.61; 95%CI,1.67, 4.08; p?<?0.001)。每标准偏差在对数生物标志物浓度的增加显着(多变量调节的大量比率,[95%置信区间],p值)与事件CKD:血浆脂联素(1.24 [1.07,1.44],p?= 0.005)和瘦素(1.3 [1.06,1.61],p?= 0.011),并用RKFD:血浆脂联素(1.22 [1.22 [1.06,1.40],p?= 0.006); HSCRP(1.17 [1.01,1.36],p?= 0.031)和醛固酮(0.85 [0.74,0.96],p?= 0.012)。醛固酮的中等水平(3rcarlyile)与入射CKD相反(0.54 [0.35,0.82],P≤00.0.004),而瘦素与RKFd相关(1.64 [1.10,2.44],p?= 0.015)。生物标志物改善了CKD风险预测(P?= 0.003),但不是RKFD风险预测(P?= 0.10)。在这种基于社区的非裔美国人样本中,与传统风险因素相比,多标记面板仅增加了中度预测性改进。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号